View in EDS HTML Full Text PDF Full Text

Voxel-Level Comparison of [18F]CETO and [11C]MTO for Molecular Imaging of Primary Aldosteronism.

Saved in:
Bibliographic Details
Title: Voxel-Level Comparison of [18F]CETO and [11C]MTO for Molecular Imaging of Primary Aldosteronism.
Authors: Gillett D; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; dg538@cam.ac.uk mg299@medschl.cam.ac.uk.; Cambridge Endocrine Molecular Imaging Group, University of Cambridge, Cambridge, United Kingdom., MacFarlane J; Cambridge Endocrine Molecular Imaging Group, University of Cambridge, Cambridge, United Kingdom., Goodchild E; Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.; NIHR Barts Cardiovascular Biomedical Research Centre, Barts, United Kingdom, and London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Endocrinology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Wu X; Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.; NIHR Barts Cardiovascular Biomedical Research Centre, Barts, United Kingdom, and London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Endocrinology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Kearney J; Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.; NIHR Barts Cardiovascular Biomedical Research Centre, Barts, United Kingdom, and London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Endocrinology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Laycock K; Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.; NIHR Barts Cardiovascular Biomedical Research Centre, Barts, United Kingdom, and London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Endocrinology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Leek F; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Crawford R; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Spink S; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Senanayake R; Cambridge Endocrine Molecular Imaging Group, University of Cambridge, Cambridge, United Kingdom.; Department of Endocrinology, Guy's and St. Thomas' Hospital NHS Trust, London, United Kingdom., Harper I; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Mendichovszky IA; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Department of Radiology, University of Cambridge, Cambridge, United Kingdom., Aloj L; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Department of Radiology, University of Cambridge, Cambridge, United Kingdom., Cheow H; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Aigbirhio FI; Molecular Imaging Chemistry Laboratory, Wolfson Brain Imaging Centre, Department of Clinical Neuroscience, University of Cambridge, Cambridge, United Kingdom; and., Drake WM; NIHR Barts Cardiovascular Biomedical Research Centre, Barts, United Kingdom, and London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Endocrinology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Brown MJ; Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.; NIHR Barts Cardiovascular Biomedical Research Centre, Barts, United Kingdom, and London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Endocrinology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Gurnell M; Cambridge Endocrine Molecular Imaging Group, University of Cambridge, Cambridge, United Kingdom; dg538@cam.ac.uk mg299@medschl.cam.ac.uk.; Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Source: Journal of nuclear medicine technology [J Nucl Med Technol] 2025 Dec 03; Vol. 53 (4), pp. 312-317. Date of Electronic Publication: 2025 Dec 03.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0430303 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5675 (Electronic) Linking ISSN: 00914916 NLM ISO Abbreviation: J Nucl Med Technol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1535-5675
DOI:10.2967/jnmt.125.270687